FCS Support Group Launched September 2016 | A group of concerned patients and care providers for a rare disease have announced the formation of the first-ever organization dedicated to providing education and support for people…
PCSK9 Inhibition: A Revolution in Cholesterol Therapy
ENDO Satellite Symposium | 2.0 AMA PRA Category 1 Credits™
Chair: Sergio Fazio, MD, PhD
Faculty: Ira J. Goldberg, MD; Kenneth R. Feingold, MD; and Evan A. Stein, MD, PhD
Keep up to date on management strategies amidst newer cholesterol-lowering therapies.
Creating Clarity for Very High Triglycerides Care
Online Course | 2.25 AMA PRA Category 1 Credits™
Faculty: Robert Eckel, MD; Michael Miller, MD; Harold Bays, MD; Sergio Fazio, MD, PhD; and Eliot Brinton, MD
Learn about the molecular underpinnings of disease and relationships to endocrinopathies using updated guidelines and case examples.
ENDO Session | No credit available
William F Young, Jr., MD, MSc
Review email consults in a computer-based CPC to learn practical approaches to diagnosing and treating hyperaldosteronism.
Heart Health Digital Toolkit
Patient Resource | No credit available
Reviewer: Robert M. Carey, MD
Check out interactive and downloadable resources and information for patients with questions about cardiovascular health and disease.
Endocrine Facts & Figures: Cardiovascular and Lipids
Research Resource | No credit available
Advisory Panel Chair: Robert A. Vigersky, MD
Updated epidemiological data and in-depth discussion on lipid disorders, cardiovascular disease, and endocrine-related risks with current citations and expert insights.
The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline JCEM | October 6, 2016 Rebecca J. Brown, David Araujo-Vilar, Pik To Cheung, David Dunger, Abhimanyu Garg, Michelle Jack, Lucy Mungai, Elif A. Oral, Nivedita Patni, Kristina I. Rother, Julia von Schnurbein, Ekaterina Sorkina, Takara Stanley, Corinne Vigouroux, Martin Wabitsch, Rachel Williams and Tohru Yorifuji
Lipodystrophy syndromes are extremely rare disorders of deficient body fat associated with potentially serious metabolic complications, including diabetes, hypertriglyceridemia, and steatohepatitis. Due to their rarity…
Cardiovascular Risk in Women with Premature Ovarian Insufficiency Compared to Premenopausal Women at Middle Age JCEM | June 14, 2016 Nadine M. P. Daan, Taulant Muka, Maria P. H. Koster, Jaenine E. Roeters van Lennep, Cornelis B. Lambalk, Joop S. E. Laven, Clemens G. K. M. Fauser, Cindy Meun, Yolanda B. de Rijke, Eric Boersma, Oscar H. Franco, Maryam Kavousi and Bart C. J. M. Fauser
A young age at menopause has been associated with increased cardiovascular disease (CVD) risk. Objective: To compare the cardiovascular risk profile between women with premature ovarian insufficiency…
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment JCEM | March 2, 2016 John W. Funder, Robert M. Carey, Franco Mantero, M. Hassan Murad, Martin Reincke, Hirotaka Shibata, Michael Stowasser, and William F. Young Jr.
For high-risk groups of hypertensive patients and those with hypokalemia, we recommend case detection of primary aldosteronism by determining the aldosterone-renin ratio under standard conditions…
Evaluation and Treatment of Hypertriglyceridemia JCEM | July 2, 2013 Lars Berglund, John D. Brunzell, Anne C. Goldberg, Ira J. Goldberg, Frank Sacks, Mohammad Hassan Murad, and Anton F. H. Stalenhoef
The Task Force recommends that the diagnosis of hypertriglyceridemia be based on fasting levels, that mild and moderate hypertriglyceridemia (triglycerides of 150–999 mg/dl) be diagnosed…